Akanda Corp AKAN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AKAN is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.09
- Day Range
- $0.09–0.09
- 52-Week Range
- $0.09–2.70
- Bid/Ask
- $0.09 / $0.10
- Market Cap
- $1.09 Mil
- Volume/Avg
- 1.6 Mil / 4.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.09
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Akanda Corp is a cannabis cultivation, manufacturing and distribution company. The Company has three reportable segments: Cultivation, Distribution and Corporate. Cultivating activities comprise the cultivation segment is made up of the medical cannabis cultivation operations at RPK/Holigen in Portugal, and medical cannabis cultivation activities. Distributing activities relate to the distribution of medical cannabis by Canmart Ltd in the United Kingdom. Corporate activities entail head office costs and other general corporate expenses related to the administration of the broader group.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 46
- Website
- https://www.akandacorp.com
Valuation
|
Metric
|
AKAN
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.02 |
Price/Sales | 0.09 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
AKAN
|
|---|---|
Quick Ratio | 0.11 |
Current Ratio | 0.26 |
Interest Coverage | −49.36 |
Quick Ratio
AKAN
Profitability
|
Metric
|
AKAN
|
|---|---|
Return on Assets (Normalized) | −39.20% |
Return on Equity (Normalized) | −56.06% |
Return on Invested Capital (Normalized) | −47.58% |
Return on Assets
AKAN
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Tgjljsdyg | Qsrkcyb | $70.9 Bil | |
ZTS
| Zoetis Inc Class A | Rymvqhsgv | Cbvq | $68.9 Bil | |
HLN
| Haleon PLC ADR | Pbwvsptn | Xscz | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Zxcsyjbzw | Syfk | $14.7 Bil | |
VTRS
| Viatris Inc | Dxfjpwcv | Cjyg | $13.7 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Wvpgllqs | Kwgt | $11.9 Bil | |
CTLT
| Catalent Inc | Jvwspzblw | Jvyvvf | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Wbbdlplv | Ybwly | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Kksccvtl | Rzlwv | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Qclgjqv | Jkcny | $3.5 Bil |